This content is machine translated Study report: Hidradenitis suppurativa Comparison of rifampicin monotherapy with clindamycin/rifampicin combination In a recent study, the inflammatory correlates in patients with hidradenitis suppurativa (HS) were analyzed before and after oral antibiotic therapy. There is evidence that the efficacy of systemic antibiotics...…
View Post 8 min This content is machine translated Hidradenitis suppurativa/acne inversa Relieving suffering and inflammation – how can this be achieved? Quite a few patients affected by hidradenitis suppurativa/acne inversa suffer from disease manifestations long before targeted therapeutic measures are taken. There are various reasons for this. One approach to tackling...…
View Post 8 min This content is machine translated Hidradenitis suppurativa Implementing innovations and improving care If hidradenitis suppurativa (HS) is not treated in time, this increases the risk of local and systemic complications. The s2k guideline published in 2024 is intended to help reduce diagnosis…
View Post 18 min This content is machine translated Hidradenitis suppurativa/acne inversa Challenges of outpatient care The disease hidradenitis suppurativa/acne inversa was first mentioned in 1839 with superficial abscesses on the axillary, submammary and perianal regions. To date, the disease has had various names: Perifolliculitis capitis… CME-Test
View Post 4 min This content is machine translated Hidradenitis suppurativa Inflammatory disease with a massive impact on quality of life The skin changes that occur in hidradenitis suppurativa (HS), particularly in the intertriginous areas, can be very distressing for those affected. For some years now, research into the complex interrelationships…
View Post 15 min This content is machine translated Hidradenitis suppurativa Etiopathogenesis, diagnosis and treatment – an update The pathogenesis of hidradenitis suppurativa (HS) has not yet been fully clarified; it is assumed that there are multifactorial interactions. The most important risk factors and comorbidities include smoking, obesity… CME-Test
View Post 5 min This content is machine translated Hidradenitis suppurativa Treatment options – status quo and outlook The management of hidradenitis suppurativa remains a clinical challenge. A combination of different therapeutic modalities is often required to achieve a sufficient degree of disease control. One study demonstrated that…
View Post 7 min This content is machine translated Acne inversa Therapy goals and progress assessment – Include “patient-reported outcomes”. Patients affected by acne inversa often have a high level of suffering due to the painful abscesses and fistulas. In addition to impaired quality of life, incapacity to work and…
View Post 4 min This content is machine translated Hidradenitis suppurativa: study report Successful treatment demonstrably improves quality of life Adalimumab (anti-TNF-α) is currently still the only approved biologic for the treatment of moderate to severe hidradenitis suppurativa (HS). In a recent “real world” 52-week study, treatment with adalimumab resulted…
View Post 5 min This content is machine translated Hidradenitis suppurativa Deciphering inflammatory pathways as the basis for new therapeutic approaches Hidradenitis suppurativa (HS) has a multifactorial etiopathogenesis and is associated with high impairment of quality of life. Empirical findings of increased expression of inflammatory cytokines suggest an immunologic genesis of…
View Post 3 min This content is machine translated Hidradenitis suppurativa Qol-HS and HS-PBI: two newly validated measurement tools for acne inversa Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a high impact on quality of life. The development of disease-related measurement tools is an important step to improve the…
